Through
11/26
A complete list of stories featured on Penn Today.
News・ Health Sciences
If Black patients were admitted to the same hospitals that serve a majority of white patients, Penn Medicine researchers show their risk of death would drop by 10%.
News・ Science & Technology
Researchers in the Goldberg Group, including Karen Goldberg, Vagelos Professor in Energy Research, and Drew Newman, doctoral candidate in chemistry, focus on alternative fuel sources for items that are part of everyday life.
News・ Sports
Past and present track & field athletes are vying for a chance to compete in the Tokyo Olympics.
News・ Science & Technology
New experiments show that, even when undisturbed, piles of sand grains are in constant motion, challenging theories of how soils and other types of disordered materials behave.
News・ Sports
The 2017 alumnus made his MLB debut for the Milwaukee Brewers on Monday against the Arizona Diamondbacks.
News・ Education, Business, & Law
A Pennsylvania high school cheerleader’s profanity-laced rant is now the foundation of a U.S. Supreme Court decision on free speech. Sigal Ben-Porath shares her arguments in her amicus brief to the court, and her predictions on the court’s decision.
News・ Arts, Humanities, & Social Sciences
In a Q&A, Frederick Dickinson of the School of Arts & Sciences talks about the politics surrounding the Tokyo Olympics and its historical significance to Japan.
News・ Arts, Humanities, & Social Sciences
Albarracín will be the Alexandra Heyman Nash University Professor, with joint appointments in the Annenberg School for Communication and the Department of Family and Community Health in the School of Nursing.
News・ Campus & Community
The award-winning author, professor, and antiracist activist joined Wharton Dean Erika James for a virtual lecture for the Penn community to commemorate the day.
News・ Health Sciences
Penn researchers are looking to mRNA vaccines for applications outside of infectious diseases, as they can not only prompt strong antibody responses to fight off invaders, like COVID-19, but also potent cytotoxic T cell responses.